Capital Research Global Investors: CVE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Research Global Investors on CVE, newest first. How the timeline and the estimate are built.
Capital Research Global Investors held 59,770,371 CVE shares at 2026-06-30 per its 13F-HR filed 2026-08-12.
the latest 13F is the newest step
- period ended2026-06-3013F 59,770,371 sharesChange vs previous 13F -45,475,174 shares
0.21% of the 13F portfolio, value $1,483,103,808.
13F-HR 0001422848-26-000094 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 105,245,545 sharesChange vs previous 13F -19,067,968 shares
0.43% of the 13F portfolio, value $2,793,243,900.
13F-HR 0001422848-26-000041 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 124,313,513 sharesChange vs previous 13F +17,730,542 shares
0.39% of the 13F portfolio, value $2,103,090,250.
13F-HR 0001422848-26-000005 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 106,582,971 sharesChange vs previous 13F +79,345,506 shares
0.34% of the 13F portfolio, value $1,809,758,056.
13F-HR 0001422848-25-000223 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 27,237,465 sharesChange vs previous 13F -2,124,256 shares
0.07% of the 13F portfolio, value $370,640,588.
13F-HR 0001422848-25-000149 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 29,361,721 sharesChange vs previous 13F +4,925,264 shares
0.09% of the 13F portfolio, value $408,039,798.
13F-HR 0000732812-25-000014 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 24,436,457 sharesChange vs previous 13F -20,029,013 shares
0.08% of the 13F portfolio, value $370,340,358.
13F-HR 0001422848-25-000010 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 44,465,470 sharesChange vs previous 13F not available
0.15% of the 13F portfolio, value $743,670,331.
13F-HR 0000017283-24-000030 filed by Capital Research Global Investors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).